5325042025-10-012025-12-315325042025-12-315325042025-04-012025-12-315325042025-10-012025-12-31in-capmkt:OtherExpenses1Member5325042025-04-012025-12-31in-capmkt:OtherExpenses1Member5325042025-10-012025-12-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15325042025-04-012025-12-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15325042025-12-31Statement15325042025-10-012025-12-31Statement15325042025-12-31StatementDynamic1I1Statement15325042025-12-31StatementDynamic1I2Statement15325042025-12-31StatementDynamic1I3Statement1iso4217:INRxbrli:pureiso4217:INRxbrli:shares532504NAVINFLUORNOTLISTEDINE048G01026Navin Fluorine International LimitedMain BoardEquity2025-04-012026-03-312026-02-092025-12-23INRCroresQuarterlyThird quarterSingle segmentChemicals2026-02-0913:45:002026-02-0916:00:00Not applicabletrue1false-2025-10-012025-12-31UnauditedStandalone57001000001987000005898800000247750000001178000005460000002160000019140000095020000043045000001594300000-1884000001405900000347000000200000347200000010587000000000105870000078000001066500000102500000220.6620.630020.6620.631.The results of the quarter and nine months ended 31st December, 2025 were reviewed by the Audit Committee and approved by the Board of Directors of the Company at its meeting held on 9th February, 2026. They have been subjected to limited review by the statutory auditors. <BR> <BR> 2.During the quarter ended 31st December, 2025 the Company paid an interim dividend of Rs. 6.50 per share (325%) on 5,12,39,124 equity shares of nominal value of Rs. 2/- each aggregating to Rs. 33.31 crores, for the financial year 2025-26. <BR> <BR> 3.During the quarter ended 30th September, 2025, the Fund raising committee at its meeting held on 11th July, 2025 has approved the allotment of 16,02,564 Equity Shares of Rs. 2/- each through Qualified Institutional Placement (QIP) under the provisions of Chapter VI of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended and section 42 and 62 of the Companies Act, 2013, including the rules made thereunder as amended, to the eligible Qualified Institutional Buyers, at the issue price of Rs. 4,680.00 per Equity Share (including a premium of 4,678.00 per Equity Share), aggregating to approximately Rs. 750 crores. <BR> Expenses incurred in relation to QIP have been adjusted from Securities Premium Account. The funds raised by the Company pursuant to QIP have been fully utilized in accordance with the 'Use of Proceeds' mentioned in the placement document of QIP. <BR> <BR> 4.Pursuant to the notification issued by the Ministry of Labour and Employment, multiple existing labour legislations have been consolidated into a unified framework comprising four Labour Codes, collectively referred to as the ' New Labour Codes ' which became effective from 21st November, 2025. The Company has reassessed its employee benefit obligations in accordance with the revised definition of wages. Accordingly, an estimated incremental liability on employee benefit amounting to Rs. 18.84 crores has been recognized as an " Exceptional item " during the quarter and nine months ended 31st December, 2025. The Company is monitoring updates on the rules and clarifications by State and / or Central Government authorities in relation to the New Labour Codes and impact of those will be evaluated and accounted for in the period in which they are notified. <BR> <BR> 5.The Company operates only in one Business Segment i.e., `Chemical Business` which constitutes single reportable segment in accordance with the requirements of Ind AS 108, ‘Operating Segments’. <BR> 2025-04-012025-12-31UnauditedStandalone1675330000068190000017435200000732260000001779000001618200000508000005770000002834600000125811000004854100000-188400000466570000010888000005050000011393000000352640000000003526400000-157000003510700000102500000269.6569.550069.6569.55Other Expenses950200000Other Expenses2834600000Remeasurement loss of the define benefit obligation1040000010400000Remeasurement loss of the define benefit obligation-21000000-210000002600000-5300000007800000-15700000QIP2025-07-1175000000002025-12-31trueCARE RATINGS LIMITEDfalseNOT APPLICABLENILNILANISH GANATRAChief Financial OfficerMUMBAI2026-02-09Repayment / pre-payment, in full or in part, of certain outstanding borrowings availed by our Company and/or its Subsidiary i.e. Navin Fluorine Advance Sciences Ltd (NFASLNot Applicable5625000000056250000000Utilised in Q2 - fy 2025-2026 Rs.415.43 cr. <br></br> Utilised in Q3 - fy 2025-2026 Rs.147.07 cr. <br></br> <br></br> Approximately Rs 750 crores has been raised in Q2 FY 2025-2026General corporate purposesNot Applicable1675000000017075000000-Issue related expensesNot Applicable20000000001675000000There was no utilisation of the issue proceeds for this object in Q3FY26